June 20-25, 2010 • Honolulu, Hawai’i
37
islh 2013 • MAY 10-12
SATURDAY AM
9:30 - 10:30
AM
Dominion North
OralAbstracts: Disease Profiling: Novel
Insights from Patient Cohort Studies
Chair(s): Linda Sandhaus, Charles Eby
9:00
O22
Analytical Validation of a Sequencing
Assay for Mutation Analysis of KIT Gene
Exons 8 and 17 in Acute Myeloid Leukemia
Gurunathan Murugesan, Jeanna Guenther-
Johnson, Kristen G. McDonnell, Harshaben
Desai, James R. Cook, Thomas M. Daly
Cleveland Clinic, Cleveland, OH, United
States
9:15
O23
FISH analysis for TET2 deletion in a cohort
of 362 Brazilian myeloid malignancies:
Correlation with karyotype abnormalities.
Fábio Oliveira, Antônio Roberto Lucena-
Araújo, Roberto Falcão, Eduardo Rego
Faculty of Medicine of Ribeirão Preto, Ribeirão
Preto, Brazil
9:30
O24
Three-dimensional nuclear telomeric
profiles in myelodysplastic syndromes and
acute myeloid leukemias
MACOURA GADJI
1,2
,
Awa Oumar Touré
1,3
,
Fatou Samba Diago Ndiaye
4
,
Abibatou Sall
1
,
Moussa Seck
1
,
Blaise Faye
1
,
Saliou Diop
1
,
Tandakha Ndiaye Dièye
1
,
Sabine Mai
2
1
The Cheikh Anta Diop University of Dakar,
Laboratory of Haematology and Immunology,
Clinical Haematology Service, National
Centre of Blood Transfusion of Dakar, BP
5002,
Dakar Fann, Dakar, Senegal,
2
The
University of Manitoba, Manitoba Institute of
Cell Biology (MICB), Cancer Care Manitoba
(
CCMB), 675 McDermot Avenue, Winnipeg,
Manitoba, Winnipeg, MB, Canada,
3
Laboratory
of Biology, HALD, Dakar, Senegal, Dakar,
Senegal,
4
The Cheikh Anta Diop University of
Dakar, Service of Internal Medicine, Clinical
Haematology Division, HALD, Dakar, Senegal
9:45
O25
Coagulation risk factors in cerebral
microbleedsand cerebral infarction. The
AGES Reykjavik study.
Pall Onundarson
1
,
Olafur Indridason
1
,
Brynja Gudmundsdottir
1
,
Gudny Eiriksdottir
2
,
Vilmundur Gudnason
2
,
Sigurlaug
Sveinbjornsdottir
3
1
Landspitali, Reykjavik, Iceland,
2
Reykjavik
Study/Hjartavernd, Reykjavik, Iceland,
3
Broomfield Hospital, Essex, United Kingdom
SAturday, MAY 11 - AM
